Dario Campana

Campana Dario

Appointment(s)
  • Professor, Department of Paediatrics
Administrative Appointment(s)
  • Director, Director, Laboratory of Immunopathology and Cell Therapy, Division of Paediatric Haematology & Oncology, National University Health System
Academic Qualifications
  • PhD, University of Milano, Italy
  • MD, University of Torino, Italy
Research Interest(s)
  • Leukaemia
  • Lymphoma
  • Cancer Immunotherapy
Recent Publications
  • 1. Kamiya, T., Wong, D., Png, Y. T., & Campana, D. (2018). A novel method to generate T-cell receptor-deficient chimeric antigen receptor T cells.. Blood Adv, 2(5), 517-528. doi:10.1182/bloodadvances.2017012823
  • 2. Png, Y. T., Vinanica, N., Kamiya, T., Shimasaki, N., Coustan-Smith, E., & Campana, D. (2017). Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies.. Blood Adv, 1(25), 2348-2360. doi:10.1182/bloodadvances.2017009928
  • 3. Taub, J. W., Berman, J. N., Hitzler, J. K., Sorrell, A. D., Lacayo, N. J., Mast, K., . . . Gamis, A. S. (2017). Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial. BLOOD, 129(25), 3304-3313. doi:10.1182/blood-2017-01-764324
  • 4. Eissa, H. M., Zhou, Y., Panetta, J. C., Browne, E. K., Jeha, S., Cheng, C., . . . Inaba, H. (2017). The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia. Blood Cancer Journal, 7(2). doi:10.1038/bcj.2017.11
  • 5. Campana, D., & Pui, C. H. (2017). Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemia. Blood, 129(14), 1913-1918. doi:10.1182/blood-2016-12-725804